Literature DB >> 27910715

How do we measure adherence to anti-tuberculosis treatment?

Salome Valencia1,2, Montserrat León2, Irene Losada3, Victor G Sequera1,2, Manuel Fernández Quevedo4, Alberto L García-Basteiro2,5,6.   

Abstract

INTRODUCTION: Completion of anti-tuberculosis (TB) treatment is of paramount importance for TB patients, as well as for the global efforts of TB control. However, there is neither a gold-standard measure to monitor adherence to TB treatment nor a widely used definition for different levels of adherence. Areas covered: in this review we aim to describe the different methods used to measure patients' adherence to anti-TB treatment, identifying their main strengths and limitations, with a focus on low resource settings. Expert commentary: there is a need for continuing the quest for a low cost, reliable and acceptable measure of adherence to TB treatment. We should harmonize treatment adherence measurement to allow adequate comparison of different interventions aimed at increasing adherence to TB treatment, although the way we ensure adherence can affect adherence endpoints themselves. The accuracy of adherence measurement is of importance in the context of drug clinical development.

Entities:  

Keywords:  Adherence; DOTs; compliance; measures; treatment; tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27910715     DOI: 10.1080/14787210.2017.1264270

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  13 in total

1.  Correlation of Linezolid Hair Concentrations with Plasma Exposure in Patients with Drug-Resistant Tuberculosis.

Authors:  Sean Wasserman; Shu Huo; Karina Ky; Ysabella Noelle Malig; Ali Esmail; Keertan Dheda; Peter Bacchetti; Roy Gerona; Gary Maartens; Monica Gandhi; John Metcalfe
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

2.  Determinants of Medication Adherence for Pulmonary Tuberculosis Patients During Continuation Phase in Dalian, Northeast China.

Authors:  Liang Du; Xu Chen; Xuexue Zhu; Yu Zhang; Ruiheng Wu; Jia Xu; Haoqiang Ji; Ling Zhou; Xiwei Lu
Journal:  Patient Prefer Adherence       Date:  2020-07-07       Impact factor: 2.711

3.  Role of Treatment Adherence, Doctor-Patient Trust, and Communication in Predicting Treatment Effects Among Tuberculosis Patients: Difference Between Urban and Rural Areas.

Authors:  Liang Du; Ruiheng Wu; Xu Chen; Jia Xu; Haoqiang Ji; Ling Zhou
Journal:  Patient Prefer Adherence       Date:  2020-11-24       Impact factor: 2.711

4.  Addressing challenges in tuberculosis adherence via performance-based payments for integrated case management: protocol for a cluster randomized controlled trial in Georgia.

Authors:  Ivdity Chikovani; Karin Diaconu; Predrag Duric; Lela Sulaberidze; Maia Uchaneishvili; Nuredin Ibrahim Mohammed; Akaki Zoidze; Sophie Witter
Journal:  Trials       Date:  2019-08-28       Impact factor: 2.279

5.  IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial.

Authors:  Helen R Stagg; Ibrahim Abubakar; Colin Nj Campbell; Andrew Copas; Marcia Darvell; Robert Horne; Karina Kielmann; Heinke Kunst; Mike Mandelbaum; Elisha Pickett; Alistair Story; Nicole Vidal; Fatima B Wurie; Marc Lipman
Journal:  BMJ Open       Date:  2019-12-17       Impact factor: 2.692

6.  Level of and associated factors for non-adherence to anti-tuberculosis treatment among tuberculosis patients in Gamo Gofa zone, southern Ethiopia: cross-sectional study.

Authors:  Dessalegn Ajema; Tamiru Shibru; Temesgen Endalew; Selamawit Gebeyehu
Journal:  BMC Public Health       Date:  2020-11-13       Impact factor: 3.295

7.  Quality of antiretroviral therapy services in Ghana: Implications for the HIV response in resource-constrained settings.

Authors:  Robert Kaba Alhassan; Courage Edem Ketor; Anthony Ashinyo; Mary Eyram Ashinyo; Jerry John Nutor; Conrad Adjadeh; Emmanuel Sarkodie
Journal:  SAGE Open Med       Date:  2021-07-31

8.  Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.

Authors:  Zekariyas Sahile; Lua Perimal-Lewis; Paul Arbon; Anthony John Maeder
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.752

9.  Perceptions of engagement in health care among patients with tuberculosis: a qualitative study.

Authors:  Jing Ren; Quanlei Li; Tianhua Zhang; Xiaomei Li; Shaoru Zhang; Jiaojiao Wright; Haini Liu; Zhongqiu Hua
Journal:  Patient Prefer Adherence       Date:  2019-01-11       Impact factor: 2.711

10.  Temporal Factors and Missed Doses of Tuberculosis Treatment. A Causal Associations Approach to Analyses of Digital Adherence Data.

Authors:  Helen R Stagg; James J Lewis; Xiaoqiu Liu; Shitong Huan; Shiwen Jiang; Daniel P Chin; Katherine L Fielding
Journal:  Ann Am Thorac Soc       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.